Activated Clotting Time (ACT) testing: Analysis of reproducibility

Journal of Extra-Corporeal Technology

Volumn 31, Issue 3, 1999, Pages 130-134

  Zucker, Marcia L ^a   Jobes, Christopher ^b   Siegel, Matt ^b   Jobes, David ^b   LaDuca, Frank M ^a  

^a International Technidyne Corporation   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Activated clotting time; Cardiac surgery; Hemochron

Indexed keywords

HEPARIN; INFUSORIAL EARTH; KAOLIN;

ACCURACY; ANTICOAGULANT THERAPY; ARTICLE; BLOOD CLOTTING TIME; CONTROLLED STUDY; DEVICE; DRUG MONITORING; HEART SURGERY; HEPARINIZATION; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY;

EID: 0033385951     PISSN: 00221058     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Hattersley PG. Activated clotting time of whole blood. JAMA. 1966;196:150-4.
2. Hill JD, Dontigny L, de Levai M, Mielke CH. A simple method of heparin management during prolonged extracorporeal circulation. Ann Thorac Surg. 1974;17:129-34.
3. Berg E, Stenbjerg S, Albrechtsen OK. Monitoring heparin and protamine therapy during cardiopulmonary bypass by activated clotting time. J Extra-Corp Technol. 1979;11: 229-35.
4. Mabry CD, Thompson BW, Read RC, Campbell GS. Activated clotting time monitoring of intraoperative heparinization: Our experience and comparison of two techniques. Surgery 1981;90:889-95.
5. Sillick PV, Amiot DM, Pancner G. Activated clotting time (ACT): The reproducibility of three techniques. J Extra-Corp Technol. 1987;19:265-7.
6. Gravlee GP, Case LD, Angert KC, Rogers AT, Miller GS. Variability of the activated coagulation time. Anesth Analg. 1988;67:469-72.
7. Bennett JA, Horrow JC. Activated coagulation time: One tube or two? J Cardiothorac Vasc Anesth. 1996;10:1-3.
8. Exner T, Burridge J, Power P, Rickard KA. An evaluation of currently available methods for plasma fibrinogen. Am J Clin Pathol. 1979;71:521-7.